Differential Effects of IL-12 Receptor Blockade with IL-12 p40 Homodimer on the Induction of CD4+ and CD8+ IFN-γ-Producing Cells

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 643-648

  Piccotti, Joseph R ^a,c   Chan, Sherri Y ^a   Li, Kewang ^a   Eichwald, Ernst J ^b   Bishop, D Keith ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN RECEPTOR; POLYMER;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; INTERFERON TYPE II; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POLYMERS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12;

EID: 0031567892     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:25.
2. Hendrzak, J. A., and M. J. Brunda. 1995. Biology of disease. Interleukin-12 biologic activity, therapeutic utility, and role in disease. Lab. Invest. 72:619.
3. + T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:547.
4. Oswald, I. P., P. Caspar, D. Jankovic, T. A. Wynn, E. J. Pearce, and A. Sher. 1994. IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J. Immunol. 153:1707.
5. Pearlman, E., F. P. Heinzel, F. E. Hazlett, Jr., and J. W. Kazura. 1995. IL-12 modulation of T helper responses to the filarial helminth, Brugia malayi. J. Immunol. 114:4658.
6. Gazzinelli, R. T., N. A. Giese, and H. C. Morse, III. 1994. In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during acquired immunodeficiency syndrome (MAIDS). J. Exp. Med. 180:2199.
7. + T cells to enhance priming tor interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
8. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
9. McKnight, A. J., G. J. Zimmer, I. Fogelman, S. F. Wolf, and A. K. Abbas. 1994. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172.
10. + T lymphocytes. J. Immunol. 155:111.
11. Via, C. S., V. Rus, M. K. Gately, and F. D. Finkelman. 1994. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J. Immunol. 153:4040.
12. Wynn, T. A., D. Jankovic, S. Hieny, K. Zioncheck, P. Jardieu, A. W. Cheever, and A. Sher. 1995. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J. Immunol. 154:3999.
13. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon. F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 170:827.
14. Stern, A. S., F. J. Podlaski, J. D. Hulmes, Y-C. E. Pan, P. M. Quinn, A. G. Wolitzky, P. C. Familletti, D. L. Stremlo, T. Truitt, R. Chizzonite, and M. K. Gately. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87:6808.
15. Gubler, U., A. O. Chau, D. S. Schoenhaut, C. M. Dwyer, W. McComas, R. Motyka, N. Nabavi, A. G. Wolitzky, P. M. Quinn, P. C. Familletti, and M. K. Gately. 1991. Coexpression of two distinct genes is required to generate secreted, bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88:4143.
16. Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R. M. Hewick, K. Kelleher, S. H. Herrmann, S. C. Clark, L. Azzoni, S. H. Chan, G. Trinchieri, and B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimer cytokine with multiple biological effects on T and natural killer cells. J. Immunol. 146:3074.
17. Gillessen, S., D. Carvajal, P. Ling, F. J. Podlaski, D. L. Stremlo, P. C. Familletti, U. Gubler, D. H. Presky, A. S. Stern, and M. K. Gately. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25: 200.
18. Ling, P., M. K. Gately, U. Gubler, A. S. Stem, P. Lin, K. Hollfelder, C. Su, Y-C. E. Pan, and J. Hakimi. 1995. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154:116.
19. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S. F. Wolf, and G. Trinchieri. 1992. Production of natural killer cell stimulatory factor (interleukm-12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387.
20. Presky, D. H., U. Gubler, R. A. Chizzonite, and M. K. Gately. 1995. IL-12 receptors and receptor antagonists. Research in Immunology. 146:439.
21. Chua, A. O., R. Chizzonite, B. B. Desai, T. P. Truitt, P. Nunes, L. J. Minetti, R. R. Warner, D. H. Presky, J. F Levine, M. K. Gately, and U. Gubler. 1994. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol. 153: 128.
22. Desai, B. B., P. M. Quinn, A. G. Wolitzky, P. K. A. Mongini, R. Chizzonite, and M. K. Gately. 1992. IL-12 receptor. II. Distribution and regulation of receptor expression. J. Immunol. 148:3125.
23. Hall, B. M. 1991. Cells mediating allograft rejection. Transplantation 51:1141.
24. Rosenberg, A. S., and A. Singer. 1992. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu. Rev. Immunol. 10:333.
25. Fitch, F. W., M. D. McKisic, D. W. Lancki, and T. F. Gajewski, 1993. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11:29.
26. + T cells. Annu. Rev. Immunol. 12:635.
27. Lowry, R. P. 1993. The relationship of IL-4, IL-10, and other cytokines to transplantation tolerance. Transplant. Sci. 3:104.
28. Charlton, B., H. Auchincloss, Jr., and C. G. Fathman. 1994. Mechanisms of transplantation tolerance. Annu. Rev. Immunol. 12:707.
29. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helpr type 1 immune response. J. Exp. Med. 177:1797.
30. Heinzel, F. P., R. M. Rerko, F. Ahmed, and E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155:730.
31. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, P. Puccelti, S, F. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 153:5167.
32. Gately, M. K., D. M. Carvajal, S. E. Connaughton, S. Gillessen, R. R. Warrier, K. D. Kolinsky, V. L. Wilkinson, C. M. Dwyer, G. F. Higgins, Jr., F. J. Podlaski, D. A. Faherty, P. C. Familletti, A. S. Stern, and D. H. Presky. 1996. IL-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann. NY Acad. Sci. In Press.
33. Piccotti, J. R., S. Y. Chan, R. E. Goodman, J. Magram, E. J. Eichwald, and D. K. Bishop, 1996. IL-12 antagonism induces Th2 responses, yet exacerbates cardiac allograft rejection: evidence against a dominant protective role for Th2 cytokines in alloimmunity. J. Immunol. 157:1951.
34. Cony, R. J., H. J. Winn, and P. S. Russell. 1973. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and Non-H-2 antigens in rejection. Transplantation 16:343.
35. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of Interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59.
36. + T cell clones secrete the Th1 pattern of cytokines. J. Immunol. 144:1744.
37. + T helper type 2 cells. J. Exp. Med. 181:5.
38. + T cell. Immunol. Today 15:107.
39. Bishop, D. K., S. Chan, W. Li, R. D. Ensley, S. Xu, and E. J. Eichwald. 1993. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation 56:892.
40. + T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 59:1155.
41. Maruo, S., K. Toyo-oka, M. Oh-hora, X.-G. Tai, H. Iwata, H. Takenaka, S. Yamada, S. Ono, T. Hamaoka, M. Kobayashi, M. Wysocka, G. Trinchieri, and H. Fujiwara. 1996. IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones. J. Immunol. 156:1748.
42. Presky, D. H., L. J. Minetti, U. Gubler, A. S. Stern, R. Chizzonite, and M. K. Gately. 1996. Analysis of the multivalent interactions between IL-12 and the high affinity 1L-12 receptor (IL-12R) complex. FASEB J. 10:A1310.
43. Presky, D. H., H. Yang, L. J. Minetti, A. O. Chua, N. Nabavi, C.-Y. Wu, M. K. Gately, and U. Gubler. 1996. A functional interleukin-12 receptor complex is composed of two β type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA. In press.
44. Braciale, T. J., and V. L. Braciale. 1991. Antigen presentation: structural themes and functional variations. Immunol. Today 12:124.
45. Sayegh, M. H., B. Watschinger, and C. B. Carpenter. 1994. Mechanisms of T cell recognition of alloantigen: the role of peptides. Transplantation 57:1295.
46. Shoskes, D. A., and K. J. Wood. 1994. Indirect presentation of MHC antigens in transplantation. Immunol. Today 15:32.
47. Glasebrook, A. L., and F. W. Fitch. 1980. Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. J. Exp. Med. 151:876.
48. Bishop, D. K., J. Shelby, and E. J. Eichwald. 1992. Mobilization of T lymphocytes following cardiac transplantation: evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Transplantation 53:849.
49. Forbes, R. D. C., N. A. Parfey, M. Gomersall, A. G. Darden, and R. D. Guttmann. 1986. Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection. J. Exp. Med. 164:1239.
50. Clement, J. D., S. Y. Chan, and D. K. Bishop. 1996. Allogeneic class I MHC requirement for alloantigen reactive helper T lymphocyte responses in vivo. Transplantation 62:388.